HCW Biologics Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $6.5M+128,862.1% YoYTTM through 31 Mar 2026
Net Income $3.5MTTM through 31 Mar 2026
Margins
| Current | |
|---|---|
| Operating Margin | 52.5% |
| Net Margin | 53.2% |
Returns
60.3%ROE
-19.7%ROA
-59.7%ROIC
Balance Sheet Health
Debt / Equity1.18x
Current Ratio0.09x
Net Debt$5.6M
Cash & Equivalents$1.2M
Quality Metrics
Earnings-Beat Rate25.0%
Dividend
No dividend
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.